FEB 08, 2017 10:30 AM PST

Obtaining non-invasive readouts and early safety signals from rodent models

Speaker
  • Chief Scientific Officer, Vium
    Biography
      Laura Schaevitz has more than 20 years of experience with In vivo animal studies. As Chief Scientific Officer at Vium, she oversees the development of animal models and draws upon her experiences as a molecular and behavioral neuroscientist to direct the application of Vium's digital metrics to the animal models. In past experiences, Laura utilized a broad spectrum of mouse models including transgenic and nutrition-induced models of neurodevelopmental disorders such as autism, schizophrenia, Rett syndrome, and blindsight. Laura received her PhD in Neuroscience at Stanford University in 2006.

    Abstract

    DATE: February 8, 2017
    TIME: 10:30am PT, 1:30pm ET

    The utility of animal models in drug development is limited, in part, by the measures available to researchers for monitoring animals. In life measures are often subjective, lack clinical relevance and can be hard to reproduce.  Conventional approaches to collecting in-life measures are labor-intensive and may introduce experimental variability, as they require frequent handling of the animals during the course of the study.  Vium’s technology platform addresses these essential problems by continuously collecting physiologically relevant data, providing researchers greater insights and consistency for in vivo studies.
     
    We present Vium’s Digital Vivarium, which combines HD video cameras and digital sensors with computer vision and machine learning to enable automatic, continuous assessment of disease progression for study animals simultaneously in the home cage.  The system measures physiologic, behavioral, environmental, husbandry-related, and disease-specific parameters.  Within specific animal models, novel metrics are identified that track disease severity and efficacy of reference compounds automatically and objectively.
     
    We have applied this method across a spectrum of disease models.  This presentation will show how novel Vium metrics can be used to assess disease in a model of lung injury and in the MRL/lpr model of Systemic Lupus Erythematosus. The result is a new paradigm for profiling the safety and efficacy of pharmacological agents that is not limited in scale and throughput by individual technicians.
     
    Learning Objectives:

    • Describe the Vium Platform and demonstrate how novel insights can be derived from non-invasive digital metrics in preclinical rodent studies
    • Continuous digital readouts of physiologic parameters provide reproducible, previously unattainable tracking of disease in Lupus and Lung Injury models as examples.
       

    Show Resources
    You May Also Like
    NOV 10, 2020 7:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    NOV 10, 2020 7:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    DEC 03, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 03, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: December 3, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Scientific cameras used in applications such as light sheet microscopy and calcium/voltage imaging put a large emphasis on high speed...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    NOV 16, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    AUG 18, 2020 10:00 AM PDT
    C.E. CREDITS
    AUG 18, 2020 10:00 AM PDT
    DATE: August 18, 2020 TIME: 10:00am PT Get deeper understanding of gene expression patterns by using assays that retain spatial organization at single cell resolution! Come learn about the n...
    Loading Comments...
    Show Resources
    Attendees
    • See more